While the deletion of Myd88 expression could suppress the inflammatory response, Myd88 has become a novel therapeutic target for many diseases related to inflammation, such as chronic obstructive pulmonary disease (COPD) and atherosclerosis [26,27]. The gene discussed is MYD88; the disease is atherosclerosis.